Skip to main content

Efficacy of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer (mCRPC) exposed to prior ketoconazole (KC).

Publication ,  Journal Article
Pond, GR; Armstrong, AJ; Wood, BA; Leopold, LH; Galsky, MD; Sonpavde, G
Published in: JOURNAL OF CLINICAL ONCOLOGY
February 10, 2012

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

February 10, 2012

Volume

30

Issue

5

Publisher

AMER SOC CLINICAL ONCOLOGY

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pond, G. R., Armstrong, A. J., Wood, B. A., Leopold, L. H., Galsky, M. D., & Sonpavde, G. (2012). Efficacy of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer (mCRPC) exposed to prior ketoconazole (KC). JOURNAL OF CLINICAL ONCOLOGY, 30(5). https://doi.org/10.1200/jco.2012.30.5_suppl.204
Pond, Gregory Russell, Andrew J. Armstrong, Brian A. Wood, Lance Howard Leopold, Matt D. Galsky, and Guru Sonpavde. “Efficacy of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer (mCRPC) exposed to prior ketoconazole (KC).JOURNAL OF CLINICAL ONCOLOGY 30, no. 5 (February 10, 2012). https://doi.org/10.1200/jco.2012.30.5_suppl.204.
Pond GR, Armstrong AJ, Wood BA, Leopold LH, Galsky MD, Sonpavde G. Efficacy of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer (mCRPC) exposed to prior ketoconazole (KC). JOURNAL OF CLINICAL ONCOLOGY. 2012 Feb 10;30(5).
Pond, Gregory Russell, et al. “Efficacy of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer (mCRPC) exposed to prior ketoconazole (KC).JOURNAL OF CLINICAL ONCOLOGY, vol. 30, no. 5, AMER SOC CLINICAL ONCOLOGY, Feb. 2012. Wos, doi:10.1200/jco.2012.30.5_suppl.204.
Pond GR, Armstrong AJ, Wood BA, Leopold LH, Galsky MD, Sonpavde G. Efficacy of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer (mCRPC) exposed to prior ketoconazole (KC). JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2012 Feb 10;30(5).

Published In

JOURNAL OF CLINICAL ONCOLOGY

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

February 10, 2012

Volume

30

Issue

5

Publisher

AMER SOC CLINICAL ONCOLOGY

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences